Cardiac Progenitor Cell Commitment Is Inhibited by Nuclear Akt Expression
Authors:
- Pearl QuijadaPQPearl Quijada
- Mark A. SussmanMSMark A. Sussman
- Broughton KBKBroughton K
- Sussman MSMSussman M
- Buxton DBDBuxton D
- Skarlatos SSSSkarlatos S
- Mohsin SMSMohsin S
- Siddiqi SSSSiddiqi S
- 15 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 108 (8) , 960-970
Abstract
Rationale: Stem cell therapies to regenerate damaged cardiac tissue represent a novel approach to treat heart disease. However, the majority of adoptively transferred stem cells delivered to damaged myocardium do not survive long enough to impart protective benefits, resulting in modest functional improvements. Strategies to improve survival and proliferation of stem cells show promise for significantly enhancing cardiac function and regeneration. Objective: To determine whether injected cardiac progenitor cells (CPCs) genetically modified to overexpress nuclear Akt (CPCeA) increase structural and functional benefits to infarcted myocardium relative to control CPCs. Methods and Results: CPCeA exhibit significantly increased proliferation and secretion of paracrine factors compared with CPCs. However, CPCeA exhibit impaired capacity for lineage commitment in vitro. Infarcted hearts receiving intramyocardial injection of CPCeA have increased recruitment of endogenous c-kit cells compared with CPCs, but neither population provides long-term functional and structural improvements compared with saline-injected controls. Pharmacological inhibition of Akt alleviated blockade of lineage commitment in CPCeA. Conclusions: Although overexpression of nuclear Akt promotes rapid proliferation and secretion of protective paracrine factors, the inability of CPCeA to undergo lineage commitment hinders their capacity to provide functional or structural benefits to infarcted hearts. Despite enhanced recruitment of endogenous CPCs, lack of functional improvement in CPCeA-treated hearts demonstrates CPC lineage commitment is essential to the regenerative response. Effective stem cell therapies must promote cellular survival and proliferation without inhibiting lineage commitment. Because CPCeA exhibit remarkable proliferative potential, an inducible system mediating nuclear Akt expression could be useful to augment cell therapy approaches.Keywords
This publication has 50 references indexed in Scilit:
- Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, AtiprimodMolecular Cancer Therapeutics, 2007
- Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathwayGenes & Development, 2006
- Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiationMolecular Therapy, 2006
- Akt Promotes Increased Cardiomyocyte Cycling and Expansion of the Cardiac Progenitor Cell PopulationCirculation Research, 2006
- Effects of Akt on Cardiac MyocytesCirculation Research, 2006
- Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophyProceedings of the National Academy of Sciences, 2006
- Bone Marrow Stem Cells Prevent Left Ventricular Remodeling of Ischemic Heart Through Paracrine SignalingCirculation Research, 2006
- The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction modelCardiovascular Research, 2006
- Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvementThe FASEB Journal, 2006
- Akt Induces β-Cell Proliferation by Regulating Cyclin D1, Cyclin D2, and p21 Levels and Cyclin-Dependent Kinase-4 ActivityDiabetes, 2006